Bizarre Patents
Smoking Cessation Lighter and Method
A lighter for tobacco products suppresses the urge to smoke by operant conditioning.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8183024 | Compositions and methods comprising a subtilisin variant The present invention provides a subtilisin variant that is particularly well suited to cleaning applications. In particular, the present invention provides a Bacillus sp. subtilisin variant and cleaning compositions comprising this variant. ... | 05/22/2012 |
| 8173409 | Acid fungal proteases The present invention is directed to novel acid proteases and more specifically to NSP24 family proteases and NSP25 family proteases including biologically active fragments thereof and to nucleic acid molecules encoding said proteases. Also provided are vectors and ... | 05/08/2012 |
| 8168242 | Situ fructooligosaccharide production and sucrose reduction The invention pertains to an in situ process for producing fructooligosaccharides in a food product by contacting the food product with a fructosyltransferase to enzymatically convert sucrose to fructooligosaccharides in the food product. The increase in fructooligo... | 05/01/2012 |
| 8158397 | Bacillus 029cel cellulase The present invention provides a novel cellulase nucleic acid sequence, designated 029cel, and the corresponding 029cel amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding 029cel, recombinant... | 04/17/2012 |
| 8148128 | Chemically modified mutant serine hydrolases show improved catalytic activity and chiral selectivity This invention provides novel chemically modified mutant serine hydrolases that catalyze a transamidation and/or a transpeptidation and/or a transesterification reaction. The modified serine hydrolases have one or more amino acid residues in a subsite replaced with ... | 04/03/2012 |
| 8148104 | Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter The invention relates to a xylanase originating from a Bacillus strain. This xylanase is active over a wide range of acid and basic pH. The invention also relates to new strains of microorganisms producing this xylanase and to methods for preparing this xylan... | 04/03/2012 |
| 8138321 | Acetolactate synthase (ALS) selectable marker from A nucleic acid encoding an acetolactate synthase (ALS) protein that provides resistance to ALS inhibitors, e.g., sulphonylurea and imidazolinone compounds, is provided. The nucleic acid may be used as a selectable marker for expression of a protein of interest in ho... | 03/20/2012 |
| 8133711 | BGL7 beta-glucosidase and nucleic acids encoding the same The present invention provides BGL7 polypeptides with the biological activity of a β-glucosidase and a method of producing a recombinant enzyme having β-glucosidase activity. ... | 03/13/2012 |
| 8124399 | Enhanced protein expression in The present invention provides cells that have been genetically manipulated to have an altered capacity to produce expressed proteins. In particular, the present invention relates to Gram-positive microorganisms, such as Bacillus species having enhanced expre... | 02/28/2012 |
| 7897742 | Twin-arginine translocation in Described herein are methods to enhance protein secretion in a host cell. In preferred embodiment, the host cell is a gram-positive microorganism such as a Bacillus. In another preferred embodiment, the host cell is a gram-negative microorganism. Preferably t... | 03/01/2011 |
| 7884192 | Twin-arginine translocation in Described herein are methods to enhance protein secretion in a host cell. In preferred embodiment, the host cell is a gram-positive microorganism such as a Bacillus. In another preferred embodiment, the host cell is a gram-negative microorganism. Preferably t... | 02/08/2011 |
| 7884191 | Twin-arginine translocation in Described herein are methods to enhance protein secretion in a host cell. In preferred embodiment, the host cell is a gram-positive microorganism such as a Bacillus. In another preferred embodiment, the host cell is a gram-negative microorganism. Preferably t... | 02/08/2011 |
| 7858762 | Phosphate limited inducible promoter and a expression system An evolvable production strain of B. subtilis exhibiting continuous or high level expression during protein evolution is described. An evolved Bacillus subtilis pstS promoter facilitates screening and production of secreted proteins. ... | 12/28/2010 |
| 7803591 | Multimeric oxidoreductases Described are multimeric oxidoreductase complexes which function in the enzymatic conversion of a carbon substrate. The complexes having a dehydrogenase subunit and a cytochrome C subunit. Also described are polynucleotides coding for the multimeric complexes and me... | 09/28/2010 |
| 7723079 | glucoamylase and homologs thereof The present invention is related to glucoamylases having at least 80% sequence identity to a Trichoderma glucoamylase having the sequence of SEQ ID NO: 4 and biologically functional fragments thereof. The invention is also related to DNA sequences coding for ... | 05/25/2010 |
| 7629451 | Acid fungal proteases The present invention is directed to novel acid proteases and more specifically to NSP24 family proteases and NSP25 family proteases including biologically active fragments thereof and to nucleic acid molecules encoding said proteases. Also provided are vectors and ... | 12/08/2009 |
| 7626004 | Protein purification The present invention relates to a method of purifying a protein of interest from its fusion analog, comprising obtaining a protein solution comprising a protein of interest and its fusion analog; adjusting the pH and/or ionic strength of the protein solution with a... | 12/01/2009 |
| 7604974 | 029cel cellulase The present invention provides a novel cellulase nucleic acid sequence, designated 029cel, and the corresponding 029cel amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding 029cel, recombinant... | 10/20/2009 |
| 7592420 | Expression in filamentous fungi of protease inhibitors and variants thereof Described herein are protease inhibitors, variants thereof and methods for their production. ... | 09/22/2009 |
| 7592157 | Expression in filamentous fungi of protease inhibitors and variants thereof Described herein are protease inhibitors, variants thereof and methods for their production. ... | 09/22/2009 |
| 7563609 | Mutant 2,5-diketo-L-gluconic acid reductases Described herein are novel nucleic acids, proteins and methods that can be used to provide new catalysts with desirable traits for industrial processes. In particular, novel reductases isolated from the environment using PCR methods are described. ... | 07/21/2009 |
| 7563607 | Acid fungal protease in fermentation of insoluble starch substrates The invention is directed to methods of producing ethanol and decreasing residual starch production in a no cook fermentation comprising contacting granular starch containing substrates with a granular starch hydrolyzing enzyme, a protease, and a fermenting microorg... | 07/21/2009 |
| 7544490 | Secretion, transcription and sporulation genes in The present invention relates to cells that have been genetically manipulated to have an altered capacity to produce expressed proteins. In particular, the present invention relates to Gram-positive microorganisms having exogenous nucleic acid sequences introduced t... | 06/09/2009 |
| 7544489 | Secretion, transcription and sporulation genes in The present invention relates to cells that have been genetically manipulated to have an altered capacity to produce expressed proteins. In particular, the present invention relates to Gram-positive microorganisms having exogenous nucleic acid sequences introduced t... | 06/09/2009 |
| 7544488 | Secretion, transcription and sporulation genes in The present invention relates to cells that have been genetically manipulated to have an altered capacity to produce expressed proteins. In particular, the present invention relates to Gram-positive microorganisms having exogenous nucleic acid sequences introduced t... | 06/09/2009 |
